Dr. Ozlem Bilen, MD

Dr. Bilen practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Bilen's NPI, 1073879573, was assigned on April 9, 2012. Dr. Bilen holds Georgia license 008825.

Dr. Bilen's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Bilen's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Bilen is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Bilen to 2 more hospitals, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bilen practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bilen's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bilen is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Bilen is licensed in Georgia.

CMS data shows 957 Medicare services from Dr. Bilen across 15 procedure codes in 2024, for 535 Medicare patients. Medicare paid $43,597 for them.

CMS counts 535 Medicare patients who saw Dr. Bilen in 2024. The largest group is 65 to 74, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bilen's median patient age at 68, with 54% women.

In 2024, Dr. Bilen wrote 2,542 Medicare Part D claims for 341 patients. 70% of them were for generic drugs. CMS names the drug for 2,370 of them, across 40 drugs with 11 or more claims each, at $1,610,405 in total drug cost. In 2023, CMS named 1,989 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Bilen for performance year 2024, reported through an alternative payment model (APM). Dr. Bilen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bilen as offering telehealth.

Dmand AI links 12 papers to Dr. Bilen, published from 2011 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Anticoagulants and Heparin. Dr. Bilen has published most often in JACC Heart Fail. Dr. Bilen's most frequent co-authors are Christie Mitchell Ballantyne, MD, Yashashwi Pokharel, MD and Theodore P. Abraham, MD.

CMS Open Payments shows 11 general payments to Dr. Bilen from 3 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $23,374.